CompletedNot Applicable

Effects of Upper Extremity Aerobic Exercise Training in Patients With Interstitial Lung Disease

Turkey (Türkiye)42 participantsStarted 2023-07-03

Plain-language summary

Severe dyspnea, cough, fatigue, restrictive type ventilation disorder, decreased pulmonary function, impaired gas exchange, decreased cardiovascular function and exercise intolerance are frequently encountered findings in patients with interstitial lung disease. It was demonstrated exercise training has beneficial effects in patients with interstitial lung disease. However, no study investigated the effects of upper extremity aerobic exercise training on outcomes in patients with interstitial lung disease.

Who can participate

Age range

18 Years – 75 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosed with ILD according to ATS/ERS criteria, * Aged between 18-75 years, * No pulmonary infection during the last month, * Patients who volunteer to participate in the study Exclusion Criteria: Patients with, * Body mass index \>35 kg/m2, * An acute pulmonary exacerbation within the last 4 weeks, have an acute upper or lower respiratory tract infection, * Presence of obstructive pulmonary disease, * Serious neurological, neuromuscular, orthopedic, or other diseases affecting physical functions, * Participated in a planned exercise program within the last three months, * Cognitive impairment that causes them to have difficulty understanding and following exercise test instructions, * Contraindications for exercise testing and/or exercise training according to the American College of Sports Medicine * Cancer, renal or hepatic diseases, * Aortic stenosis, complex arrhythmia, with aortic aneurysm, * Uncontrolled hypertension, diabetes mellitus, heart failure, arrhythmia and serious cardiovascular disease

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Oxygen consumption

Timeframe: through study completion, an average of 2 year

Muscle oxygenation

Timeframe: through study completion, an average of 2 year

Physical activity level

Timeframe: through study completion, an average of 2 year

Trial details

NCT IDNCT05916404

SponsorGazi University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-05-01

View on ClinicalTrials.gov More Interstitial Lung Disease trials

Plain-language summary

Who can participate

Age range

18 Years – 75 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.